GSK registers three new Phase 3 trials spanning asthma, prostate cancer, ovarian cancerSep 30Weekly roundup, 8 itemsgepotidacinGlaxoSmithKlineUpdated
New Phase Ib myeloma study registered; GSK-linked FTD trial terminated, BRCA study postedSep 24Weekly roundup, 3 itemsAL001Alector, Inc.
GSK's IPF drug GSK3915393 fails Phase 2 on futility; expanded access opens for velzatinib in GISTSep 18Weekly roundup, 2 itemsGlaxoSmithKlineGSK3915393
GSK registers Phase 3 trials for mRNA flu vaccine and prostate cancer ADC Ris-RezSep 4Weekly roundup, 2 itemsGlaxoSmithKlinerisvutatug rezetecan
GSK posts results for 2021 COVID-19 SAM vaccine trial; advances four Phase 3 respiratory studiesAug 27Weekly roundup, 7 itemsefimosfermin alfaganfeborole
NIAID-led IMPAACT 2026 pharmacokinetic study terminated early, results postedAug 26Trial updateGilead SciencesGlaxoSmithKline
Japan approves GSK's Hibsago as first functional cure for chronic hepatitis BAug 24Regulatory decisionbepirovirsenGlaxoSmithKline
GSK posts propellant trial results; recruits for three Phase 3 felcorekibart studiesAug 21Weekly roundup, 5 itemsGlaxoSmithKlineGSK5784283
Lilly registers Phase 3 depression trial; posts results for two psoriasis and oncology studiesAug 20Weekly roundup, 5 itemsabemaciclibbrenipatide
GSK-linked trials: six new registrations this week, all not yet recruitingAug 6Weekly roundup, 6 itemsaletekitugbelantamab
Hansoh's Ris-Rez hits PFS endpoint in second phase III osteosarcoma trialJul 28Clinical readoutGlaxoSmithKlinerisvutatug rezetecan
Summit reports Q2 2026 results as HARMONi OS data hold up in western patientsJul 23Clinical readoutGlaxoSmithKlineivonescimab
GSK wins US approval for Jideytro in previously treated ROS1-positive lung cancerJul 22Regulatory decisionGlaxoSmithKlinezidesamtinib
Montefiore registers Phase 1 trial pairing Talquetamab with belantamab mafodotin in myelomaJul 22Trial updatebelantamabbelantamab mafodotin
GSK halts camlipixant development in refractory chronic cough after mixed phase III resultsJul 17Clinical readoutcamlipixantGlaxoSmithKline
GSK CMV vaccine trial posts results; six new studies span cardiovascular, MASH, CRSwNPJul 17Weekly roundup, 6 itemsdepemokimabefimosfermin alfa
GSK posts bepirovirsen QT results; registers Mo-Rez ovarian, endometrial Phase 3 trialsJul 10Weekly roundup, 6 itemsbepirovirsencamlipixant
Sign in